CATH Superfamily 1.20.1250.10
The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 19: Interleukin 20
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 7 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Interleukin-20 receptor binding GO:0045517
Interacting selectively and non-covalently with the interleukin-20 receptor.
|
3 | Q9NYY1 (/TAS) Q9NYY1 (/TAS) Q9NYY1 (/TAS) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
2 | Q9JKV9 (/IDA) Q9JKV9 (/IDA) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
2 | Q9JKV9 (/ISS) Q9JKV9 (/ISS) |
Interleukin-20 receptor binding GO:0045517
Interacting selectively and non-covalently with the interleukin-20 receptor.
|
2 | Q9JKV9 (/IDA) Q9JKV9 (/IDA) |
Interleukin-20 receptor binding GO:0045517
Interacting selectively and non-covalently with the interleukin-20 receptor.
|
2 | Q9JKV9 (/IPI) Q9JKV9 (/IPI) |
Interleukin-22 receptor binding GO:0045518
Interacting selectively and non-covalently with the interleukin-22 receptor.
|
2 | Q9JKV9 (/IPI) Q9JKV9 (/IPI) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
1 | Q9UHD0 (/TAS) |
There are 15 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
4 | Q9NYY1 (/TAS) Q9NYY1 (/TAS) Q9NYY1 (/TAS) Q9UHD0 (/TAS) |
Positive regulation of tyrosine phosphorylation of STAT protein GO:0042531
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
|
3 | Q9NYY1 (/TAS) Q9NYY1 (/TAS) Q9NYY1 (/TAS) |
Positive regulation of epidermal cell differentiation GO:0045606
Any process that activates or increases the frequency, rate or extent of epidermal cell differentiation.
|
3 | Q9NYY1 (/TAS) Q9NYY1 (/TAS) Q9NYY1 (/TAS) |
Positive regulation of keratinocyte differentiation GO:0045618
Any process that activates or increases the frequency, rate or extent of keratinocyte differentiation.
|
3 | Q9NYY1 (/TAS) Q9NYY1 (/TAS) Q9NYY1 (/TAS) |
Regulation of inflammatory response GO:0050727
Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.
|
3 | Q9NYY1 (/TAS) Q9NYY1 (/TAS) Q9NYY1 (/TAS) |
Negative regulation of low-density lipoprotein particle clearance GO:0010989
Any process that decreases the rate, frequency or extent of low-density lipoprotein particle clearance. Low-density lipoprotein particle clearance is the process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
|
2 | Q8CJ70 (/IMP) Q8CJ70 (/IMP) |
Hemopoiesis GO:0030097
The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates.
|
2 | Q9JKV9 (/NAS) Q9JKV9 (/NAS) |
Interleukin-6 biosynthetic process GO:0042226
The chemical reactions and pathways resulting in the formation of interleukin-6.
|
2 | Q8CJ70 (/IDA) Q8CJ70 (/IDA) |
Positive regulation of osteoclast differentiation GO:0045672
Any process that activates or increases the frequency, rate or extent of osteoclast differentiation.
|
2 | Q9JKV9 (/IMP) Q9JKV9 (/IMP) |
Reactive oxygen species metabolic process GO:0072593
The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers.
|
2 | Q8CJ70 (/IDA) Q8CJ70 (/IDA) |
Positive regulation of apoptotic signaling pathway GO:2001235
Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway.
|
2 | Q8CJ70 (/IDA) Q8CJ70 (/IDA) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
2 | Q8CJ70 (/IDA) Q8CJ70 (/IDA) |
Positive regulation of intrinsic apoptotic signaling pathway GO:2001244
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
2 | Q8CJ70 (/IGI) Q8CJ70 (/IGI) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
1 | Q9UHD0 (/NAS) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | Q9UHD0 (/NAS) |
There are 3 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
4 | Q9NYY1 (/TAS) Q9NYY1 (/TAS) Q9NYY1 (/TAS) Q9UHD0 (/TAS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | Q9JKV9 (/IDA) Q9JKV9 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | Q9UHD0 (/NAS) |